Αρχική World News Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause Status,... World News Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause Status, Age, or Other Hormone Levels Από Ogkologos - 4 Αυγούστου, 2026 212 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RxPONDER study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR A Propensity Score Matched Study Supports the Use of Allogeneic HSCT... 12 Μαΐου, 2023 How People With Cancer Can Benefit From Online Therapy 22 Οκτωβρίου, 2020 Contact X-ray Brachytherapy Dose Escalation Increases the Organ Preservation Rate in... 29 Νοεμβρίου, 2024 Welcome to our new committee chairs 22 Νοεμβρίου, 2022 Φόρτωση περισσοτέρων HOT NEWS Cemiplimab Outperforms Investigator’s Choice Chemotherapy in the Second-Line Setting for Recurrent/Metastatic... FDA Approves Niraparib and Abiraterone Acetate Plus Prednisone for BRCA2-mutated Metastatic Castration-Sensitive Prostate Cancer Topotecan–Berzosertib Combination Shows Promise against Small Cell Lung Cancer In the Name of Pinkness